Gore Ventures
Gore Ventures
Visit Booth T-20 to explore our synthetic cornea device and connect with our team. Discover how we’re advancing vision restoration with cutting-edge innovation!
The Carbontech Leadership Council (CLC) is an invitation-only group of corporate, non-profit, and government thought leaders who foster commercialization opportunities and identify avenues for technology validation, testing, and demonstration.
Recently, reinvigorated efforts in developing fully synthetic flexible devices have resulted in several prototypes now undergoing clinical trials.
The Federal Commission for Protection against Sanitary Risks (COFEPRIS) has recently authorized a pioneering clinical trial, which aims to assess the effectiveness of the GORE synthetic cornea device in patients suffering from corneal clarity loss.
Join Dr. Juan Batlle at the AGS 2025 Annual Meeting for a presentation on the Gore investigational device, its design, materials and early clinical results on sub-conjunctival scarring, a key cause of filtering surgery failure.
Mitico, a pioneering carbon capture technology company, today announced it raised $4.3 million in seed funding to scale its innovative granulated metal carbonate sorption technology capturing carbon dioxide (CO2) emitted from industries. The round led …
This fundraise brings in new investments from Sofinnova Partners, Fall Line Capital, Sucden Ventures, Silver Blue, and the venture arm of W. L. Gore & Associates (makers of Gore-Tex®), which has been in a joint development agreement with Arzeda since 2022.
Since the first successful full thickness corneal transplantation was performed by Eduard Zirm in 1905, the procedure has grown to become the most commonly performed transplantation globally.
The objective of this early feasibility clinical study is to evaluate the safety and effectiveness of the GORE Glaucoma Drainage Implant (2 configurations) in subjects with primary open-angle glaucoma that is uncontrolled by hypotensive medications or for which conventional incisional glaucoma surgery would be more likely to fail due to scarring.
Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not “sell” the personal information of website users. Gore may “share” the personal information of website users, as standard advertising practice meant to offer you a more personalized service.
If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.
Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.
You Have Successfully Opted Out of the Sharing of Your Personal Information
Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.